MTVA
MetaVia Inc.
NASDAQHealthcareBiotechnologyUS
Rating:B
Company Profile
CEO
Hyung Heon Kim
IPO Date
2016-08-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
MetaVia Inc.
CEO
Hyung Heon Kim
IPO Date
2016-08-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 17,186 |
| $0.00 |
| 8 Jun 2026 | Salsbury Michael | director | A-Award | Acquired | 17,186 | $0.00 |
| 8 Jun 2026 | GROVES JASON L | director | A-Award | Acquired | 17,186 | $0.00 |
| 8 Jun 2026 | KOVEN ANDREW I | director | A-Award | Acquired | 17,186 | $0.00 |
| 8 Jun 2026 | Glickman Mark A | director | A-Award | Acquired | 17,186 | $0.00 |
| 27 Jan 2026 | Woodworth Marshall H | Chief Financial Officer | A-Award | Acquired | 28,000 | $0.00 |
| 27 Jan 2026 | Kim Hyung Heon | director, officer: CEO & President | A-Award | Acquired | 32,000 | $0.00 |
| 13 Aug 2025 | Woodworth Marshall H | Chief Financial Officer | G-Gift | Disposed | 14,200 | $0.00 |
| 1 Jul 2025 | Glickman Mark A | director | A-Award | Acquired | 28,147 | $0.00 |